LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
SYPR
Sypris Solutions, Inc.
There isn't enough reported data to score SYPR yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SYPR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
SYPR's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SYPR PE Valuation
SYPR has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SYPR Forward outlook
There aren't enough analyst estimates for SYPR to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over SYPR on earnings, with more consistent year-over-year improvement.
SYPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.47 | -$0.36 |
| Q1 2026 | -$0.42 | -$0.40 |
| Q4 2025 | -$0.28 | -$0.20 |
| Q3 2025 | -$0.11 | +$0.01 |
| Q2 2025 | -$0.11 | +$0.06 |
| Q1 2025 | -$0.02 | +$0.14 |
| Q4 2024 | -$0.08 | -$0.01 |
| Q3 2024 | -$0.12 | -$0.10 |
SYPR lost $0.47 per share over the past year, and its loss has widened in each of the last three quarters.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SYPR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SYPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $30.3M | -3.5% |
| Q1 2026 | $25.8M | -13% |
| Q4 2025 | $30.3M | -9.5% |
| Q3 2025 | $28.7M | -20% |
| Q2 2025 | $31.4M | -12% |
| Q1 2025 | $29.5M | -17% |
| Q4 2024 | $33.4M | -3.7% |
| Q3 2024 | $35.7M | +6.2% |
SYPR's revenue is shrinking: $30M last quarter, down 3.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.1% | -3.5 points |
| Q1 2026 | -14% | -14 points |
| Q4 2025 | -11% | -15 points |
| Q3 2025 | -6.1% | -11 points |
| Q2 2025 | -4.6% | -8.2 points |
| Q1 2025 | -0.4% | +3.4 points |
| Q4 2024 | 3.9% | +4.7 points |
| Q3 2024 | 4.8% | +5.2 points |
SYPR has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SYPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.5M | +61% |
| Q1 2026 | -$2.6M | +$3M |
| Q4 2025 | -$1.5M | -179% |
| Q3 2025 | -$390K | +$4.5M |
| Q2 2025 | $941K | -84% |
| Q1 2025 | -$5.5M | -$3.5M |
| Q4 2024 | $1.9M | +$5.1M |
| Q3 2024 | -$4.9M | +$7.3M |
SYPR has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SYPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +92K shares |
| 1 year | +0.6% | +136K shares |
| 3 years | -0.1% | -25K shares |
| 5 years | -1.9% | -425K shares |
| Available history | +7.1% | +1.5M shares |
SYPR has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SYPR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -1.6x | Net Cash |
SYPR has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SYPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 5.1 | Oversold |
SYPR's weekly RSI is 30 (neutral) and its Stochastic is 5 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SYPR PE vs Consumer Cyclical Sector
| Metric | SYPR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
SYPR has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SYPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.59 | 30% below |
| 20 week MA | $1.78 | 38% below |
| 50 week MA | $2.50 | 56% below |
| 100 week MA | $2.24 | 50% below |
| 200 week MA | $2.03 | 45% below |
SYPR is in a downtrend: it's below all five of its weekly moving averages, and 45% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SYPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.80 | $1.43 | +79% |
| 2021 | $1.43 | $2.45 | +71% |
| 2022 | $2.45 | $2.08 | -15% |
| 2023 | $2.08 | $2.03 | -2.4% |
| 2024 | $2.03 | $2.07 | +2% |
| 2025 | $2.07 | $2.32 | +12% |
| 2026 YTD | $2.32 | $1.11 | -52% |
SYPR has the edge over LCID on returns for 2026, with the stronger performance.